Seranovo

SeraNovo is a global leader in pharmaceutical formulation innovation, specializing in enhancing the oral bioavailability of complex small molecules and peptides. Our proprietary technology unlocks the full potential of even the most challenging active ingredients, transforming them into viable therapeutic products. Founded in 2017 and based in the Netherlands, SeraNovo has successfully addressed difficult formulation challenges for a diverse, global client base, helping to advance promising medical therapies toward clinical success. Driven by a culture of innovation, SeraNovo's achievements are backed by a robust portfolio of intellectual property, ensuring our solutions remain at the forefront of pharmaceutical advancements.